Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
CIBC Atlas Equity Income Institutional AWYIX
- NAV / 1-Day Return 59.75 / +0.98 %
- Total Assets 327.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.900%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 1.40%
- Turnover 27%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:08 PM GMT+0
Morningstar’s Analysis AWYIX
Will AWYIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 5.70 | 17.5 Mil | Healthcare |
Microsoft Corp | 5.09 | 15.6 Mil | Technology |
Enterprise Products Partners LP | 4.98 | 15.3 Mil | Energy |
AstraZeneca PLC ADR | 4.34 | 13.3 Mil | Healthcare |
Elevance Health Inc | 4.16 | 12.7 Mil | Healthcare |
Blackstone Inc | 3.95 | 12.1 Mil | Financial Services |
Abbott Laboratories | 3.36 | 10.3 Mil | Healthcare |
L3Harris Technologies Inc | 3.23 | 9.9 Mil | Industrials |
FTAI Aviation Ltd | 2.88 | 8.8 Mil | Industrials |
CME Group Inc Class A | 2.86 | 8.8 Mil | Financial Services |